Published in Caries Res on February 07, 2001
Laser-induced autofluorescence study of caries model in vitro. Lasers Med Sci (2006) 0.85
Studies on strains of Streptococcus mutans isolated from caries-active and caries-free individuals in Iceland. J Oral Microbiol (2012) 0.78
Bacteriocins of gram-positive bacteria. Bacteriol Rev (1976) 10.66
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Assay system for bacteriocins. Appl Microbiol (1971) 3.05
Dental caries is a preventable infectious disease. Aust Dent J (2000) 1.98
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol (1979) 1.97
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol (2001) 1.63
Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother (1975) 1.59
Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol (1993) 1.56
Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother (1973) 1.54
A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol (2006) 1.54
Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol (1993) 1.36
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol (2000) 1.24
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16
Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol (2011) 1.13
Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek (1996) 1.12
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa. Med J Aust (1971) 1.12
An inhibitor typing scheme for Streptococcus uberis. J Dairy Res (1986) 1.12
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev Biol Stand (1995) 1.09
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions. Epidemiol Infect (1991) 1.09
Persistently infected cultures as a source of hepatitis A virus. Appl Environ Microbiol (1985) 1.08
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis (2008) 1.08
Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol (1979) 1.06
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) (1983) 1.04
Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J Med Microbiol (2002) 1.04
Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol Lett (2000) 1.03
Factors affecting production of the group A streptococcus bacteriocin SA-FF22. J Med Microbiol (1992) 1.03
Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol (1983) 1.03
Genetic basis of streptococcin A-FF22 production. Antimicrob Agents Chemother (1976) 1.02
The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol (1982) 1.00
Transduction of bacteriocin determinants in group A streptococci. J Exp Med (1976) 0.99
Some possible autoimmune mechanisms in rheumatic carditis. Lancet (1972) 0.99
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (2011) 0.97
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother (1978) 0.97
The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis (2005) 0.97
Functional characterization of domains found within a lytic enzyme produced by Streptococcus equi subsp. zooepidemicus. FEMS Microbiol Lett (2002) 0.95
M-type 57 group A streptococcus bacteriocin. Can J Microbiol (1983) 0.95
Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol (1983) 0.95
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun (1999) 0.95
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol (1996) 0.92
Beneficial microbes for the oral cavity: time to harness the oral streptococci? Benef Microbes (2011) 0.92
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett (1992) 0.91
Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth. J Appl Bacteriol (1981) 0.90
Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types. J Clin Microbiol (1984) 0.89
Use of an inhibitor typing scheme to study the epidemiology of Streptococcus uberis mastitis. N Z Vet J (1988) 0.88
Zoocin A immunity factor: a femA-like gene found in a group C streptococcus. FEMS Microbiol Lett (1998) 0.88
Suspected periodontopathic microorganisms and their oral habitats in young children. Oral Microbiol Immunol (1987) 0.88
Production of broad-spectrum bacteriocin-like activity by group A streptococci of particular M-types. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.87
Bacteriocin production by group a streptococcal L-forms. Antimicrob Agents Chemother (1976) 0.87
Bacteriocin-like inhibitory activity associated with beta-hemolytic strains of Streptococcus salivarius. J Dent Res (1987) 0.86
Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A. J Gen Microbiol (1973) 0.86
Proteinase-related broad-spectrum inhibitory activity among group-A streptococci. J Med Microbiol (1986) 0.84
Genetic basis for mutacin N and of its relationship to mutacin I. Indian J Med Res (2004) 0.84
Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci. Oral Microbiol Immunol (1997) 0.84
A bacteriocin produced by certain M-type 49 Streptococcus pyogenes strains when incubated anaerobically. J Hyg (Lond) (1984) 0.83
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 2. "Fingerprinting" of Ps. aeruginosa strains in a study of cross-infection in a children's hospital. Med J Aust (1971) 0.83
A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius. J Clin Microbiol (2000) 0.82
Heart-reactive antibodies in rheumatic fever. Med J Aust (1972) 0.82
Development of a method to quantify in vitro the synergistic activity of "natural" antimicrobials. Int J Food Microbiol (2003) 0.82
High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever. N Z Med J (2000) 0.81
Pyocine typing as an epidemiological marker in Pseudomonas aeruginosa mastitis in cattle. J Hyg (Lond) (1971) 0.81
Suspected periodontopathic bacteria associated with broken-mouth periodontitis in sheep. J Periodontal Res (1988) 0.80
Zoocin A and lauricidin in combination reduce Streptococcus mutans growth in a multispecies biofilm. Caries Res (2012) 0.80
Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.80
Microbially-produced peptides having potential application to the prevention of dental caries. Int J Antimicrob Agents (1997) 0.79
The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci. N Z Dent J (1991) 0.78
Bacteriocin production by Streptococcus salivarius strain P. Can J Microbiol (1981) 0.78
Evaluation of a typing scheme for group A streptococci based upon bacteriocin-like inhibitor production. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.77
Evaluation of stored lamb bio-preserved using a three-strain cocktail of Lactobacillus sakei. Meat Sci (2010) 0.77
Myoid cell antibody in rheumatic fever. Immunol Commun (1973) 0.77
Black-pigmented Bacteroides associated with broken-mouth periodontitis in sheep. J Periodontal Res (1987) 0.77
Pyocin-sensitivity testing as a means of typing Pseudomonas aeruginosa. J Med Microbiol (1973) 0.77
Inhibition of foodborne bacteria by the lactoperoxidase system in a beef cube system. Int J Food Microbiol (2004) 0.76
Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media. J Clin Microbiol (1986) 0.75
Environmental influences on the progression of clinical and microbiological parameters of sheep periodontal disease. Res Vet Sci (1989) 0.75
Inhibition of bacterial foodborne pathogens by the lactoperoxidase system in combination with monolaurin. Int J Food Microbiol (2002) 0.75
Incidence and characterization of anti-microbial effects produced by Actinomyces viscosus and Actinomyces naeslundii. J Dent Res (1986) 0.75
Toxic shock syndrome. N Z Med J (1987) 0.75
An inhibitor typing scheme applicable to Lancefield group E streptococci. Can J Microbiol (1985) 0.75
Streptolysin S: purification and properties. Zentralbl Bakteriol Orig A (1978) 0.75
Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows. J Appl Microbiol (2006) 0.75
Quantification of the bacterium Bacteroides gingivalis in human dental plaque by detection of the trypsin-like protease activity of colonies imprinted on membrane filters. Arch Oral Biol (1987) 0.75
Bacterial interference and toxic shock syndrome. Ann Intern Med (1983) 0.75